Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

HealthLynked (HLYK) Cash from Investing Activities (2016 - 2024)

HealthLynked (HLYK) has disclosed Cash from Investing Activities for 9 consecutive years, with $425000.0 as the latest value for Q4 2024.

  • On a quarterly basis, Cash from Investing Activities fell 64.17% to $425000.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $422402.0, a 87.95% decrease, with the full-year FY2024 number at $422402.0, down 87.95% from a year prior.
  • Cash from Investing Activities was $425000.0 for Q4 2024 at HealthLynked, up from -$2598.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $2.6 million in Q3 2020 to a low of -$613631.0 in Q4 2020.
  • A 5-year average of $337912.9 and a median of -$6775.0 in 2021 define the central range for Cash from Investing Activities.
  • Peak YoY movement for Cash from Investing Activities: soared 45979.67% in 2020, then crashed 197.53% in 2022.
  • HealthLynked's Cash from Investing Activities stood at -$613631.0 in 2020, then skyrocketed by 98.9% to -$6775.0 in 2021, then crashed by 90.2% to -$12886.0 in 2022, then skyrocketed by 9305.58% to $1.2 million in 2023, then plummeted by 64.17% to $425000.0 in 2024.
  • Per Business Quant, the three most recent readings for HLYK's Cash from Investing Activities are $425000.0 (Q4 2024), -$2598.0 (Q1 2024), and $1.2 million (Q4 2023).